Advertisement
Home 2015

Archives

The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme.

FDA Approves Optune Device for Newly Diagnosed Glioblastoma

0
Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide
U.S. hospitals have made significant improvements to breastfeeding support programs in recent years

CDC: Hospitals Doing Better Job of Promoting Breastfeeding

0
Still, nearly 4 million infants are born each year in U.S., but only 14% in 'baby-friendly' hospitals
The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation statement

USPSTF Recommends CRC Screening for 50- to 75-Year-Olds

0
Grade A recommendation for 50- to 75-year-olds; individualized decision urged for those age 76 to 85
California Gov. Jerry Brown signed "right-to-die" legislation on Monday that will allow the terminally ill to legally end their lives.

California Governor Signs Right-to-Die Bill Into Law

0
Physicians can now prescribe life-ending drugs to terminally ill
Aristada (aripiprazole lauroxil) extended-release injection has been approved by the U.S. Food and Drug Administration to treat schizophrenia

FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia

0
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
A new treatment for melanoma that combines two cancer drugs has been approved by the U.S. Food and Drug Administration. The therapy for advanced melanoma includes the drugs Yervoy (ipilimumab) and Opdivo (nivolumab)

FDA Approves New Combo Therapy for Melanoma

0
Yervoy and Opdivo previously approved individually to treat melanoma
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test

FDA Approves Keytruda for Advanced NSCLC

0
Approved for use with PD-L1 IHC 22C3 pharmDx test
Two new diabetes treatments

FDA Approves Two New Medications for Diabetes

0
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
The estimated prevalence of HIV is 0.39 percent among U.S adults

CDC Estimates HIV Prevalence in U.S. Adults From ’07 to ’12

0
Prevalence estimated at 0.39 percent; 51.9 percent of HIV-infected on antiretroviral tx
A new report commissioned by the U.S. government contends that most Americans will encounter at least one diagnostic error in their lifetime

IOM: Most U.S. Patients Will Experience Diagnostic Error

0
Panel urges changes to an increasingly complex health care system